Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MSF.BR Stock Summary
Top 10 Correlated ETFs
MSF.BR
In the News
MSF.BR Financial details
Company Rating
-
Market Cap
2390.15B
Income
72.36B
Revenue
211.92B
Book val./share
27.74
Cash/share
14.97
Dividend
2.72
Dividend %
0.86%
Employees
221K
Optionable
No
Shortable
Yes
Earnings
23 Oct 2023
P/E
32.39
Forward P/E
-
PEG
3141.83
P/S
11.05
P/B
11.37
P/C
21.49
P/FCF
39.39
Quick Ratio
1.54
Current Ratio
1.77
Debt / Equity
0.29
LT Debt / Equity
0.27
-
-
EPS (TTM)
9.71
EPS next Y
-
EPS next Q
-
EPS this Y
0.21%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
13.72%
Revenue last 5Y
10.99%
Revenue Q/Q
6.3%
EPS Q/Q
9.76%
-
-
-
-
SMA20
2.33%
SMA50
-2.85%
SMA100
8.45%
Inst Own
-
Inst Trans
-
ROA
18%
ROE
38%
ROC
0.29%
Gross Margin
69%
Oper. Margin
42%
Profit Margin
34%
Payout
27%
Shs Outstand
7.43B
Shs Float
7.42B
-
-
-
-
Target Price
-
52W Range
212.75-364.45
52W High
-11.62%
52W Low
+51.75%
RSI
42.95
Rel Volume
0.66
Avg Volume
91
Volume
60
Perf Week
-2.29%
Perf Month
-0.09%
Perf Quarter
10.93%
Perf Half Y
15.24%
-
-
-
-
Beta
0.904564
-
-
Volatility
6.71%, 5.88%
Prev Close
0.78%
Price
321.7
Change
0.55%
MSF.BR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 16.4 | 18.79 | 22.27 | 26.45 | 28.46 | |
Net income per share | 5.11 | 5.82 | 8.12 | 9.7 | 9.72 | |
Operating cash flow per share | 6.8 | 7.97 | 10.17 | 11.88 | 11.76 | |
Free cash flow per share | 4.99 | 5.94 | 7.44 | 8.69 | 7.99 | |
Cash per share | 17.44 | 17.94 | 17.27 | 13.98 | 14.94 | |
Book value per share | 13.34 | 15.55 | 18.81 | 22.22 | 27.7 | |
Tangible book value per share | 6.85 | 8.92 | 11.19 | 11.7 | 17.32 | |
Share holders equity per share | 13.34 | 15.55 | 18.81 | 22.22 | 27.7 | |
Interest debt per share | 10.56 | 9.67 | 9.29 | 8.45 | 8.05 | |
Market cap | 1035.86B | 1529.61B | 2036.94B | 1913.35B | 2558.82B | |
Enterprise value | 1102.87B | 1587.03B | 2090.49B | 1960.69B | 2584.08B | |
P/E ratio | 26.4 | 34.54 | 33.24 | 26.3 | 35.36 | |
Price to sales ratio | 8.23 | 10.7 | 12.12 | 9.65 | 12.07 | |
POCF ratio | 19.85 | 25.21 | 26.54 | 21.49 | 29.22 | |
PFCF ratio | 27.07 | 33.82 | 36.3 | 29.37 | 43.02 | |
P/B Ratio | 10.12 | 12.93 | 14.35 | 11.49 | 12.41 | |
PTB ratio | 10.12 | 12.93 | 14.35 | 11.49 | 12.41 | |
EV to sales | 8.76 | 11.1 | 12.44 | 9.89 | 12.19 | |
Enterprise value over EBITDA | 20.18 | 24.14 | 25.62 | 20.04 | 25.24 | |
EV to operating cash flow | 21.13 | 26.16 | 27.24 | 22.02 | 29.5 | |
EV to free cash flow | 28.83 | 35.08 | 37.25 | 30.1 | 43.45 | |
Earnings yield | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 | |
Free cash flow yield | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | |
Debt to equity | 0.77 | 0.6 | 0.48 | 0.37 | 0.29 | |
Debt to assets | 0.27 | 0.24 | 0.2 | 0.17 | 0.15 | |
Net debt to EBITDA | 1.23 | 0.87 | 0.66 | 0.48 | 0.25 | |
Current ratio | 2.53 | 2.52 | 2.08 | 1.78 | 1.77 | |
Interest coverage | 15.99 | 20.44 | 29.8 | 40.42 | 0 | |
Income quality | 1.33 | 1.37 | 1.25 | 1.22 | 1.21 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.35 | 0.34 | 0.27 | 0.25 | 0.27 | |
Sales general and administrative to revenue | 0.04 | 0.04 | 0.03 | 0.03 | 0.04 | |
Research and developement to revenue | 0.13 | 0.13 | 0.12 | 0.12 | 0.13 | |
Intangibles to total assets | 0.17 | 0.17 | 0.17 | 0.22 | 0.19 | |
Capex to operating cash flow | -0.27 | -0.25 | -0.27 | -0.27 | -0.32 | |
Capex to revenue | -0.11 | -0.11 | -0.12 | -0.12 | -0.13 | |
Capex to depreciation | -1.19 | -1.21 | -1.76 | -1.65 | -2.03 | |
Stock based compensation to revenue | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | |
Graham number | 39.17 | 45.11 | 58.62 | 69.65 | 77.82 | |
ROIC | 0.21 | 0.22 | 0.27 | 0.3 | 0.26 | |
Return on tangible assets | 0.17 | 0.18 | 0.22 | 0.25 | 0.22 | |
Graham Net | -3.55 | -2.83 | -4.19 | -7.8 | -7.62 | |
Working capital | 106.13B | 109.61B | 95.75B | 74.6B | 80.11B | |
Tangible asset value | 52.55B | 67.92B | 84.48B | 87.72B | 128.97B | |
Net current asset value | -8.67B | -1.09B | -7.39B | -28.61B | -21.5B | |
Invested capital | 0.77 | 0.6 | 0.48 | 0.37 | 0.29 | |
Average receivables | 28B | 30.77B | 35.03B | 41.15B | 46.47B | |
Average payables | 9B | 10.96B | 13.85B | 17.08B | 18.55B | |
Average inventory | 2.36B | 1.98B | 2.27B | 3.19B | 3.12B | |
Days sales outstanding | 85.63 | 81.7 | 82.61 | 81.48 | 83.86 | |
Days payables outstanding | 79.8 | 99.25 | 105.96 | 110.69 | 100.28 | |
Days of inventory on hand | 17.55 | 15.01 | 18.42 | 21.8 | 13.85 | |
Receivables turnover | 4.26 | 4.47 | 4.42 | 4.48 | 4.35 | |
Payables turnover | 4.57 | 3.68 | 3.44 | 3.3 | 3.64 | |
Inventory turnover | 20.8 | 24.32 | 19.81 | 16.74 | 26.35 | |
ROE | 0.38 | 0.37 | 0.43 | 0.44 | 0.35 | |
Capex per share | -1.81 | -2.03 | -2.73 | -3.19 | -3.77 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q4
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 6.94 | 6.72 | 7.08 | 7.1 | 7.56 | |
Net income per share | 2.24 | 2.35 | 2.2 | 2.46 | 2.7 | |
Operating cash flow per share | 3.3 | 3.11 | 1.5 | 3.28 | 3.87 | |
Free cash flow per share | 2.38 | 2.27 | 0.66 | 2.4 | 2.67 | |
Cash per share | 14.02 | 14.38 | 13.35 | 14.03 | 14.97 | |
Book value per share | 22.28 | 23.28 | 24.58 | 26.16 | 27.74 | |
Tangible book value per share | 11.74 | 12.78 | 14.08 | 15.71 | 17.35 | |
Share holders equity per share | 22.28 | 23.28 | 24.58 | 26.16 | 27.74 | |
Interest debt per share | 8.26 | 8.15 | 8.13 | 8.2 | 8.07 | |
Market cap | 1907.74B | 1774.77B | 1789.73B | 2113.24B | 2554.69B | |
Enterprise value | 1955.08B | 1812.16B | 1834.2B | 2147.2B | 2579.96B | |
P/E ratio | 28.49 | 25.27 | 27.24 | 28.87 | 31.8 | |
Price to sales ratio | 36.78 | 35.41 | 33.93 | 39.98 | 45.47 | |
POCF ratio | 77.46 | 76.51 | 160.18 | 86.46 | 88.8 | |
PFCF ratio | 107.43 | 104.92 | 365.33 | 118.5 | 128.85 | |
P/B Ratio | 11.45 | 10.23 | 9.77 | 10.85 | 12.39 | |
PTB ratio | 11.45 | 10.23 | 9.77 | 10.85 | 12.39 | |
EV to sales | 37.7 | 36.16 | 34.77 | 40.62 | 45.92 | |
Enterprise value over EBITDA | 79.76 | 72.73 | 76.28 | 82.9 | 91.72 | |
EV to operating cash flow | 79.38 | 78.12 | 164.16 | 87.85 | 89.68 | |
EV to free cash flow | 110.1 | 107.13 | 374.4 | 120.4 | 130.12 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0 | 0.01 | 0.01 | |
Debt to equity | 0.37 | 0.35 | 0.33 | 0.31 | 0.29 | |
Debt to assets | 0.17 | 0.17 | 0.16 | 0.16 | 0.15 | |
Net debt to EBITDA | 1.93 | 1.5 | 1.85 | 1.31 | 0.9 | |
Current ratio | 1.78 | 1.84 | 1.93 | 1.91 | 1.77 | |
Interest coverage | 41.4 | 43.04 | 41.63 | 45.06 | 0 | |
Income quality | 1.47 | 1.32 | 0.68 | 1.34 | 1.43 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.28 | 0.26 | 0.31 | 0.28 | 0.25 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.04 | 0.03 | 0.04 | |
Research and developement to revenue | 0.13 | 0.13 | 0.13 | 0.13 | 0.12 | |
Intangibles to total assets | 0.22 | 0.22 | 0.21 | 0.2 | 0.19 | |
Capex to operating cash flow | -0.28 | -0.27 | -0.56 | -0.27 | -0.31 | |
Capex to revenue | -0.13 | -0.13 | -0.12 | -0.12 | -0.16 | |
Capex to depreciation | -1.73 | -2.25 | -1.72 | -1.86 | -2.31 | |
Stock based compensation to revenue | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | |
Graham number | 33.51 | 35.11 | 34.92 | 38.05 | 41.06 | |
ROIC | 0.07 | 0.07 | 0.06 | 0.07 | 0.07 | |
Return on tangible assets | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
Graham Net | -7.82 | -7.16 | -7.19 | -6.92 | -7.63 | |
Working capital | 74.6B | 73.42B | 76.11B | 78.2B | 80.11B | |
Tangible asset value | 87.72B | 95.3B | 104.88B | 116.86B | 128.97B | |
Net current asset value | -28.61B | -25.41B | -23.59B | -21.52B | -21.5B | |
Invested capital | 0.37 | 0.35 | 0.33 | 0.31 | 0.29 | |
Average receivables | 38.44B | 37.77B | 33.56B | 36.63B | 43.05B | |
Average payables | 17.54B | 17.8B | 15.98B | 15.33B | 16.7B | |
Average inventory | 3.52B | 4.01B | 3.62B | 2.93B | 2.69B | |
Days sales outstanding | 76.8 | 56.17 | 61.14 | 63.72 | 77.99 | |
Days payables outstanding | 104.08 | 96.74 | 79.02 | 85.41 | 96.97 | |
Days of inventory on hand | 20.5 | 24.86 | 15.34 | 16.05 | 13.4 | |
Receivables turnover | 1.17 | 1.6 | 1.47 | 1.41 | 1.15 | |
Payables turnover | 0.86 | 0.93 | 1.14 | 1.05 | 0.93 | |
Inventory turnover | 4.39 | 3.62 | 5.87 | 5.61 | 6.72 | |
ROE | 0.1 | 0.1 | 0.09 | 0.09 | 0.1 | |
Capex per share | -0.92 | -0.84 | -0.84 | -0.89 | -1.2 |
MSF.BR Frequently Asked Questions
What is Microsoft Corporation stock symbol ?
Microsoft Corporation is a US stock , located in Redmond of Wa and trading under the symbol MSF.BR
What is Microsoft Corporation stock quote today ?
Microsoft Corporation stock price is $321.7 today.
Is Microsoft Corporation stock public?
Yes, Microsoft Corporation is a publicly traded company.